Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Market Research Future | PRODUCT CODE: 1517290

Cover Image

PUBLISHER: Market Research Future | PRODUCT CODE: 1517290

US Medical Second Opinion Market Research Report Information Based on Diagnosis, Service Provider, and Mode of Payment Projection for the year 2030

PUBLISHED:
PAGES: 50 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2950
PDF & Excel (Multi User License)
USD 3950
PDF & Excel (Enterprise License)
USD 5250

Add to Cart

US Medical Second Opinion Market Research Report Information Based on Diagnosis (Cancer, Cardiovascular Disease, Spine Procedures, Neurology Conditions, Others), Service Provider (Hospitals, Physicians/Specialists, Medical Second Opinion Companies, Health Insurance Companies), and Mode of Payment (Online, Offline, and Others) Projection for the year 2030

Market Overview

It is anticipated that the US Medical Second Opinion Market will experience a robust CAGR of 116.11% during the review period. The U.S. medical second opinion market is experiencing growth due to the increasing demand for healthcare cost optimization, the rising preference for improved diagnosis and treatment planning, and the growing number of cancer cases. Nevertheless, the market growth is expected to be impeded by the high cost of a medical second opinion and the lack of awareness among the general public.

The recommendations of another physician for a course of therapy are either confirmed or modified by a second doctor's opinion. The diagnosis, course of therapy, and prognosis may be significantly affected by obtaining a second medical opinion. The patient can mitigate unnecessary risks by optimizing the course of treatment. Healthcare organizations benefit from improved care, quality control, and cost savings from unneeded operations and treatments, while physicians benefit from reduced exposure to legal claims. Nevertheless, the misuse of this technology can lead to exorbitant medical expenses.

Market Segmentation

The US Medical Second Opinion Market is categorized into the following categories: Cancer Cardiovascular Disease, Spine Procedures, Neurology Conditions, and Others, based on the diagnosis.

Service providers have been classified into hospitals, physicians/specialists, medical second opinion companies, and health insurance companies.

The market is segmented into Online, Offline, and Other categories based on the mode of payment.

Major Players

SecondOpinionExpert, Inc., Included Health, Inc., AccessHope, LLC, and 2nd.MD are the primary participants in the US Medical Second Opinion Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 GROWING PREFERENCE FOR HEALTHCARE COST OPTIMIZATION
    • 4.2.2 INCREASING NEED TO IMPROVE DIAGNOSIS AND TREATMENT PLANNING
    • 4.2.3 INCREASING NUMBER OF CANCER CASES
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST OF MEDICAL SECOND OPINION
    • 4.3.2 LACK OF AWARENESS AMONG PEOPLE
  • 4.4 OPPORTUNITIES
    • 4.4.1 RISING NUMBER OF STRATEGIC INITIATIVES

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 SERVICE
    • 5.1.3 SALES AND MARKETING
    • 5.1.4 CONTRACT MANAGEMENT
    • 5.1.5 CUSTOMER SERVICE & SUPPORT
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE US MEDICAL SECOND OPINION MARKET
    • 5.3.1 IMPACT ON VALUE CHAIN
    • 5.3.2 IMPACT ON DEMAND
    • 5.3.3 IMPACT ON REGION
    • 5.3.4 IMPACT ON KEY PLAYERS

6 US MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS

  • 6.1 OVERVIEW
  • 6.2 CANCER
  • 6.3 CARDIOVASCULAR/HEART DISORDERS
  • 6.4 SPINE PROCEDURES
  • 6.5 NEUROLOGY CONDITIONS
  • 6.6 OTHERS

7 US MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS PHYSICIANS/SPECIALTIES
  • 7.3 ONLINE PHYSICIANS PORTAL
  • 7.4 MEDICAL SECOND OPINION COMPANIES
  • 7.5 HEALTH INSURANCE COMPANIES

8 US MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT

  • 8.1 OVERVIEW
  • 8.2 ONLINE PAYMENT
  • 8.3 OFFLINE PAYMENT

9 COMPANY PROFILES

  • 9.1 SECONDOPINIONEXPERT, INC.
    • 9.1.1 COMPANY OVERVIEW
    • 9.1.2 FINANCIAL OVERVIEW
    • 9.1.3 PRODUCTS OFFERED
    • 9.1.4 KEY DEVELOPMENTS
    • 9.1.5 SWOT ANALYSIS
    • 9.1.6 KEY STRATEGIES
  • 9.2 INCLUDED HEALTH, INC.
    • 9.2.1 COMPANY OVERVIEW
    • 9.2.2 FINANCIAL OVERVIEW
    • 9.2.3 PRODUCTS OFFERED
    • 9.2.4 KEY DEVELOPMENTS
    • 9.2.5 SWOT ANALYSIS
    • 9.2.6 KEY STRATEGIES
  • 9.3 ACCESSHOPE, LLC
    • 9.3.1 COMPANY OVERVIEW
    • 9.3.2 FINANCIAL OVERVIEW
    • 9.3.3 PRODUCTS OFFERED
    • 9.3.4 KEY DEVELOPMENTS
    • 9.3.5 SWOT ANALYSIS
    • 9.3.6 KEY STRATEGIES
  • 9.4 NAVVISA
    • 9.4.1 COMPANY OVERVIEW
    • 9.4.2 FINANCIAL OVERVIEW
    • 9.4.3 SERVICES OFFERED
    • 9.4.4 KEY DEVELOPMENTS
    • 9.4.5 KEY STRATEGIES
  • 9.5 2ND.MD
    • 9.5.1 COMPANY OVERVIEW
    • 9.5.2 FINANCIAL OVERVIEW
    • 9.5.3 SERVICES OFFERED
    • 9.5.4 SWOT ANALYSIS
    • 9.5.5 KEY DEVELOPMENTS
    • 9.5.6 KEY STRATEGIES

10 APPENDIX

  • 10.1 REFERENCES
  • 10.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 US: MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 4 US: MEDICAL SECOND OPINION MARKET, FOR CANCER, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5 US: MEDICAL SECOND OPINION MARKET, FOR CANCER, BY TYPE, 2018-2030 (UNITS)
  • TABLE 6 US: MEDICAL SECOND OPINION MARKET, FOR OTHER CANCER, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 7 US: MEDICAL SECOND OPINION MARKET, FOR CARDIOVASCULAR/HEART DISORDERS, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8 US: MEDICAL SECOND OPINION MARKET, FOR CARDIOVASCULAR/HEART DISORDERS, BY TYPE, 2018-2030 (UNITS)
  • TABLE 9 US: MEDICAL SECOND OPINION MARKET, FOR SPINE PROCEDURES, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10 US: MEDICAL SECOND OPINION MARKET, FOR NEUROLOGY CONDITIONS, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11 US: MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
  • TABLE 12 US: MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT, 2018-2030 (USD MILLION)
  • TABLE 13 SECONDOPINIONEXPERT, INC.: SERVICES OFFERED
  • TABLE 14 INCLUDED HEALTH, INC.: SERVICES OFFERED
  • TABLE 15 INCLUDED HEALTH, INC.: KEY DEVELOPMENTS
  • TABLE 16 ACCESSHOPE, LLC: SERVICES OFFERED
  • TABLE 17 ACCESSHOPE, LLC: KEY DEVELOPMENTS
  • TABLE 18 NAVVISA: SERVICES OFFERED
  • TABLE 19 2ND.MD: SERVICES OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 US MEDICAL SECOND OPINION MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE US MEDICAL SECOND OPINION MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: US MEDICAL SECOND OPINION MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: US MEDICAL SECOND OPINION MARKET
  • FIGURE 9 US: MEDICAL SECOND OPINION MARKET, BY DIAGNOSIS, 2021 & 2030 (USD MILLION)
  • FIGURE 10 US: MEDICAL SECOND OPINION MARKET, BY SERVICE PROVIDER, 2021 & 2030 (USD MILLION)
  • FIGURE 11 US: MEDICAL SECOND OPINION MARKET, BY MODE OF PAYMENT, 2021 & 2030 (USD MILLION)
  • FIGURE 12 SECONDOPINIONEXPERT, INC.: SWOT ANALYSIS
  • FIGURE 13 INCLUDED HEALTH, INC.: SWOT ANALYSIS
  • FIGURE 14 ACCESSHOPE, LLC: SWOT ANALYSIS
  • FIGURE 15 2ND.MD: SWOT ANALYSIS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!